CN101268051B - 同位素取代的质子泵抑制剂 - Google Patents

同位素取代的质子泵抑制剂 Download PDF

Info

Publication number
CN101268051B
CN101268051B CN2006800345034A CN200680034503A CN101268051B CN 101268051 B CN101268051 B CN 101268051B CN 2006800345034 A CN2006800345034 A CN 2006800345034A CN 200680034503 A CN200680034503 A CN 200680034503A CN 101268051 B CN101268051 B CN 101268051B
Authority
CN
China
Prior art keywords
methoxyl group
group
compound
pyridyl
benzoglyoxaline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2006800345034A
Other languages
English (en)
Chinese (zh)
Other versions
CN101268051A (zh
Inventor
B·科尔
B·米勒
D·哈格
W·-A·西蒙
K·泽克
M·戴维
O·冯里克特
F·休思
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Nycomed GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed GmbH filed Critical Nycomed GmbH
Publication of CN101268051A publication Critical patent/CN101268051A/zh
Application granted granted Critical
Publication of CN101268051B publication Critical patent/CN101268051B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN2006800345034A 2005-07-26 2006-07-26 同位素取代的质子泵抑制剂 Expired - Fee Related CN101268051B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05106868.2 2005-07-26
EP05106868 2005-07-26
PCT/EP2006/064666 WO2007012650A1 (en) 2005-07-26 2006-07-26 Isotopically substituted proton pump inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN2011100224850A Division CN102134232B (zh) 2005-07-26 2006-07-26 同位素取代的质子泵抑制剂

Publications (2)

Publication Number Publication Date
CN101268051A CN101268051A (zh) 2008-09-17
CN101268051B true CN101268051B (zh) 2011-08-31

Family

ID=35734406

Family Applications (2)

Application Number Title Priority Date Filing Date
CN2011100224850A Expired - Fee Related CN102134232B (zh) 2005-07-26 2006-07-26 同位素取代的质子泵抑制剂
CN2006800345034A Expired - Fee Related CN101268051B (zh) 2005-07-26 2006-07-26 同位素取代的质子泵抑制剂

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN2011100224850A Expired - Fee Related CN102134232B (zh) 2005-07-26 2006-07-26 同位素取代的质子泵抑制剂

Country Status (17)

Country Link
EP (1) EP1910293A1 (ko)
JP (1) JP5448448B2 (ko)
KR (1) KR101358509B1 (ko)
CN (2) CN102134232B (ko)
AR (1) AR054584A1 (ko)
AU (1) AU2006274036B2 (ko)
BR (1) BRPI0614039A2 (ko)
CA (1) CA2615670C (ko)
EA (1) EA016814B1 (ko)
HK (2) HK1125098A1 (ko)
IL (1) IL188773A (ko)
MX (1) MX2008000901A (ko)
NO (1) NO20080839L (ko)
NZ (1) NZ565078A (ko)
TW (1) TWI394750B (ko)
WO (1) WO2007012650A1 (ko)
ZA (1) ZA200800303B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI410409B (zh) * 2005-07-26 2013-10-01 Takeda Gmbh 同位素取代之潘托拉唑（ｐａｎｔｏｐｒａｚｏｌｅ）
AU2006299424A1 (en) * 2005-10-06 2007-04-12 Auspex Pharmaceuticals, Inc. Deuterated inhibitors of gastric H+, K+-ATPase with enhanced therapeutic properties
WO2008127640A2 (en) * 2007-04-11 2008-10-23 Auspex Pharmaceuticals, Inc. Substituted benzimidazoles
WO2008130863A2 (en) * 2007-04-11 2008-10-30 Auspex Pharmaceuticals, Inc. Substituted benzimidazoles
EP2534144B1 (en) 2010-02-12 2014-09-03 Esteve Química, S.A. Preparation process of the sodium salt of Esomeprazole
CN104530003A (zh) * 2014-06-10 2015-04-22 广东东阳光药业有限公司 吡啶甲基亚磺酰基-1h-苯并咪唑类化合物的盐的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005129A1 (en) * 1978-04-14 1979-10-31 Aktiebolaget Hässle Substituted pyridylsulfinylbenzimidazoles having gastric acid secretion properties, pharmaceutical preparations containing same, and intermediates for their preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0643426B2 (ja) * 1986-07-25 1994-06-08 東京田辺製薬株式会社 イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
KR100477070B1 (ko) * 1994-03-25 2006-04-21 이소테크니카 인코포레이티드 중수소화작용에의한의약품의효능강화법
US6334997B1 (en) * 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
US6884429B2 (en) * 1997-09-05 2005-04-26 Isotechnika International Inc. Medical devices incorporating deuterated rapamycin for controlled delivery thereof
NO309305B1 (no) * 1999-02-19 2001-01-15 Norsk Hydro As Anvendelse av benzaldehydderivater ved fremstilling av farmasöytiske preparater for forebygging og/eller behandling av kreft, samt visse nye benzaldehydderivater
DE10123129A1 (de) * 2001-05-02 2002-11-14 Berolina Drug Dev Ab Svedala Deuterierte 3-Piperidinopropiophenone sowie diese Verbindungen enthaltende Arzneimittel
DE10162121A1 (de) * 2001-12-12 2003-06-18 Berolina Drug Dev Ab Svedala Deuterierte substituierte Pyrazolyl-Benzolsulfonamide sowie diese Verbindungen enthaltende Arzneimittel
TWI410409B (zh) * 2005-07-26 2013-10-01 Takeda Gmbh 同位素取代之潘托拉唑（ｐａｎｔｏｐｒａｚｏｌｅ）

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005129A1 (en) * 1978-04-14 1979-10-31 Aktiebolaget Hässle Substituted pyridylsulfinylbenzimidazoles having gastric acid secretion properties, pharmaceutical preparations containing same, and intermediates for their preparation

Also Published As

Publication number Publication date
CA2615670A1 (en) 2007-02-01
KR101358509B1 (ko) 2014-02-05
ZA200800303B (en) 2009-01-28
IL188773A0 (en) 2008-08-07
IL188773A (en) 2014-02-27
JP5448448B2 (ja) 2014-03-19
TWI394750B (zh) 2013-05-01
CN102134232B (zh) 2012-11-21
MX2008000901A (es) 2008-03-26
KR20080037676A (ko) 2008-04-30
EA016814B1 (ru) 2012-07-30
JP2009502871A (ja) 2009-01-29
AR054584A1 (es) 2007-06-27
HK1125098A1 (en) 2009-07-31
CA2615670C (en) 2015-01-20
BRPI0614039A2 (pt) 2011-03-09
HK1160126A1 (en) 2012-08-10
AU2006274036B2 (en) 2012-05-24
WO2007012650A1 (en) 2007-02-01
EP1910293A1 (en) 2008-04-16
NO20080839L (no) 2008-02-18
NZ565078A (en) 2010-03-26
AU2006274036A1 (en) 2007-02-01
CN101268051A (zh) 2008-09-17
CN102134232A (zh) 2011-07-27
TW200714596A (en) 2007-04-16
AU2006274036A2 (en) 2008-03-20
EA200800203A1 (ru) 2008-08-29

Similar Documents

Publication Publication Date Title
CN101268050B (zh) 同位素取代的泮托拉唑
JP4002303B2 (ja) Ｓ−オメプラゾールの新規な形態
CN101268051B (zh) 同位素取代的质子泵抑制剂
NO331505B1 (no) (-) Enantiomeren av tenatoprazol, farmasoytisk preparat inneholdende denne samt anvendelse av denne for fremstilling av medisinsk preparat for behandling av sykdom
CN100558726C (zh) 泰妥拉唑的对映体及其在治疗中的应用
US7629361B2 (en) Salt of (S)-pantoprazole and its hydrates
KR101258744B1 (ko) 술폭시화물 유도체의 광학 선택적 제조 방법
CN102712591B (zh) 3-羟基吡啶-4-酮的氟化衍生物
US7601737B2 (en) Isotopically substituted proton pump inhibitors
CN1964971A (zh) 作为质子泵抑制剂的氨基－卤素－咪唑并吡啶
MXPA99010945A (en) Novel form of s

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1125098

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1125098

Country of ref document: HK

C56 Change in the name or address of the patentee

Owner name: TAKEDA GMBH

Free format text: FORMER NAME: NYCOMED INC.

CP01 Change in the name or title of a patent holder

Address after: Konstanz

Patentee after: Nycomed GmbH

Address before: Konstanz

Patentee before: Nycomed GmbH

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110831

Termination date: 20150726

EXPY Termination of patent right or utility model